Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: Arimoclomol citrate [mi], 368860-21-3, Arimoclomol citrate [usan], Unii-q85ffy6179, Q85ffy6179, Orphazyme a/s
Molecular Formula
C20H28ClN3O10
Molecular Weight
505.9  g/mol
InChI Key
XSENLDLUMVYRET-BTQNPOSSSA-N
FDA UNII
Q85FFY6179

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[(2R)-2-hydroxy-3-piperidin-1-ylpropoxy]-1-oxidopyridin-1-ium-3-carboximidoyl chloride;2-hydroxypropane-1,2,3-tricarboxylic acid
2.1.2 InChI
InChI=1S/C14H20ClN3O3.C6H8O7/c15-14(12-5-4-8-18(20)9-12)16-21-11-13(19)10-17-6-2-1-3-7-17;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-5,8-9,13,19H,1-3,6-7,10-11H2;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t13-;/m1./s1
2.1.3 InChI Key
XSENLDLUMVYRET-BTQNPOSSSA-N
2.2 Other Identifiers
2.2.1 UNII
Q85FFY6179
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Arimoclomol Citrate [mi]

2. 368860-21-3

3. Arimoclomol Citrate [usan]

4. Unii-q85ffy6179

5. Q85ffy6179

6. Orphazyme A/s

7. 3-pyridinecarboximidoyl Chloride, N-((2r)-2-hydroxy-3-(1-piperidinyl)propoxy)-, 1-oxide, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)

8. Arimoclomol Citrate (usan)

9. N-[(2r)-2-hydroxy-3-piperidin-1-ylpropoxy]-1-oxidopyridin-1-ium-3-carboximidoyl Chloride;2-hydroxypropane-1,2,3-tricarboxylic Acid

10. N-((2r)-2-hydroxy-3-(1-piperidyl)propoxy)pyridine-3-carboximidoyl Chloride, 1-oxide, 2-hydroxy-1,2,3-propanetricarboxylate

11. N-[(2r)-2-hydroxy-3-(1-piperidyl)propoxy]pyridine-3-carboximidoyl Chloride, 1-oxide, 2-hydroxy-1,2,3-propanetricarboxylate

12. Schembl2681096

13. Da-61204

14. Q27287107

15. 855-142-3

16. Arimoclomol Citrate; 3-pyridinecarboximidoyl Chloride, N-[(2r)-2-hydroxy-3-(1-piperidinyl)propoxy]-, 1-oxide, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); 3-pyridinecarboximidoyl Chloride, N-[(2r)-2-hydroxy-3-(1-piperidinyl)propoxy]-, 1-oxide, 2-hydroxy-1,2,3-propanetricarbox

2.3.2 Other Synonyms

1. Arimoclomol

2.4 Create Date
2014-01-31
3 Chemical and Physical Properties
Molecular Weight 505.9 g/mol
Molecular Formula C20H28ClN3O10
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count12
Rotatable Bond Count11
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area203
Heavy Atom Count34
Formal Charge0
Complexity565
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count1
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

Treatment of amyotrophic lateral sclerosis


Treatment of amyotrophic lateral sclerosis, Treatment of sporadic inclusion body myositis


Treatment of Niemann-Pick disease, type C